Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

CICC

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 211
Average round size
info
The average size of a deal this fund participated in
$101M
Portfolio companies 196
Rounds per year 7.28
Lead investments 42
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.07
Exits 28
Key employees 9
Stages of investment
Early Stage Venture
Late Stage Venture

Areas of investment

  • Health Care
  • Manufacturing
  • Medical
  • Biotechnology
  • Information Technology
Summary

CICC appeared to be the VC, which was created in 1995. The leading representative office of defined VC is situated in the Beijing. The company was established in Asia in China.

The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the CICC, startups are often financed by Matrix Partners China, Legend Capital, BlueRun Ventures. The meaningful sponsors for the fund in investment in the same round are IDG Capital, CDH Investments, Sequoia Capital China. In the next rounds fund is usually obtained by Sinowisdom, Primavera Capital Group, PICC Asset Management.

The overall number of key employees were 9.

The higher amount of exits for fund were in 2019. Considering the real fund results, this VC is 22 percentage points more often commits exit comparing to other organizations. Comparing to the other companies, this CICC performs on 13 percentage points less the average number of lead investments. The fund is constantly included in 2-6 deals per year. The important activity for fund was in 2018. The common things for fund are deals in the range of more than 100 millions dollars. The average startup value when the investment from CICC is more than 1 billion dollars.

Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. The fund has exact preference in a number of founders of portfolio startups. If startup sums 5+ of the founder, the chance for it to be financed is low. For fund there is a match between the country of its foundation and the country of its the most frequent investments - China. Among the most popular portfolio startups of the fund, we may highlight Lu.com, JD Digits, Zhong An. Among the most popular fund investment industries, there are Finance, Automotive.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of CICC:
Typical Co-investors
CICC is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after CICC:

Funds with similar focus

Funds from China
Funds with similar focus located in China:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Ouyeel Semiconductor

Automotive
Autonomous Vehicles
Semiconductor
29 Dec 2023 Shenzhen, Guangdong, China

Innovo Therapeutics

Biotechnology
Medical
Product Research
$15M01 Dec 2023 San Diego, California, United States

Ubi Technology

Artificial Intelligence
Internet of Things
12 Oct 2023 Zhengzhou, Henan, China

Pet Marvel

Electronics
Pet
$15M27 Sep 2023 Minhang, Shanghai, China

GRIT Biotechnology

Biotechnology
Health Care
Medical Device
$61M08 Sep 2023 Shanghai, Shanghai, China

Leilong Technology

B2B
Enterprise Software
Insurance
08 Aug 2023 Shanghai, Shanghai, China

ICE Bioscience InC.

Biotechnology
Health Care
Medical
$15M03 Aug 2023 -

Daqin New Energy

Energy
Energy Management
Energy Storage
26 Jul 2023 Xian, Hunan, China

Astronergy

Energy
Manufacturing
Solar
$309M25 Jul 2023 Hangzhou, Zhejiang, China

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent CICC?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 211
Average round size 101M
Rounds per year 7.28
Peak activity year 2022
Lead investments 42
Follow on index 0.07
Exits 28
Group Appearance index 0.87

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Ouyeel Semiconductor

Automotive
Autonomous Vehicles
Semiconductor
29 Dec 2023 Shenzhen, Guangdong, China

Innovo Therapeutics

Biotechnology
Medical
Product Research
$15M01 Dec 2023 San Diego, California, United States

Ubi Technology

Artificial Intelligence
Internet of Things
12 Oct 2023 Zhengzhou, Henan, China

Pet Marvel

Electronics
Pet
$15M27 Sep 2023 Minhang, Shanghai, China

GRIT Biotechnology

Biotechnology
Health Care
Medical Device
$61M08 Sep 2023 Shanghai, Shanghai, China

Leilong Technology

B2B
Enterprise Software
Insurance
08 Aug 2023 Shanghai, Shanghai, China

ICE Bioscience InC.

Biotechnology
Health Care
Medical
$15M03 Aug 2023 -

Daqin New Energy

Energy
Energy Management
Energy Storage
26 Jul 2023 Xian, Hunan, China

Astronergy

Energy
Manufacturing
Solar
$309M25 Jul 2023 Hangzhou, Zhejiang, China
Crunchbase icon

Content report

The following text will be sent to our editors: